<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02365493</url>
  </required_header>
  <id_info>
    <org_study_id>NHMRC1078930</org_study_id>
    <nct_id>NCT02365493</nct_id>
  </id_info>
  <brief_title>Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection</brief_title>
  <acronym>CAMERA2</acronym>
  <official_title>CAMERA 2 - Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection - An Investigator-initiated, Multi-centre, Parallel Group, Open Labelled Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Menzies School of Health Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Australasian Society for Infectious Diseases</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Singapore Infectious Diseases Clinical Research Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of Queensland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Australasian Kidney Trials Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Menzies School of Health Research</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this clinical trial is to determine whether a novel combination antibiotic
      treatment (vancomycin/daptomycin + beta-lactam) is superior to the standard antibiotic
      treatment (vancomycin/daptomycin) for hospitalised adults with Methicillin Resistant
      Staphylococcus aureus bacteraemia. The hypothesis is that the addition of beta-lactam
      antibiotics (these are antibiotics from the penicillin family) to the standard therapy will
      lead to more efficient bacterial killing and hence lead to faster clearance of bacteria from
      the blood stream and other areas of infection, thereby reducing the risk of the spread of
      infection and death.

      The study design is an investigator-initiated, multi-centre, open-label, randomised
      controlled trial. This will include 440 participants diagnosed with Methicillin Resistant
      Staphylococcus aureus bacteraemia recruited over a period of 4 years (July 2015 - June 2019)
      from within Infectious Diseases inpatient units across 21 hospital sites including 18 from
      within Australia and 3 located in Singapore. Participation will be voluntary and subject to
      informed consent. The participants will be randomised 1:1 to either the standard therapy
      group or combination therapy group. The combination therapy will include a treatment of
      intravenous beta-lactam for the first 7 days of treatment, in addition to the standard
      treatment (either vancomycin or daptomycin). The primary outcome measure will be
      complication-free survival 90 days post randomisation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complication-free 90 day survival</measure>
    <time_frame>Time period from randomisation (day 1) to day 90</time_frame>
    <description>Composite outcome at 90 days - any of:
All-cause mortality
Persistent bacteraemia at day 5 or beyond
Microbiological relapse - positive blood culture for MRSA at least 72 hours after a preceding negative culture
Microbiological treatment failure. Positive sterile site culture for MRSA at least 14 days after randomisation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality at days 14, 42 and 90 days</measure>
    <time_frame>Time period from randomisation (day 1) to day 90</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent bacteraemia at day 2</measure>
    <time_frame>Time period from randomisation (day 1) to day 90</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent bacteraemia at day 5 or beyond</measure>
    <time_frame>Time period from randomisation (day 1) to day 90</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute kidney injury defined as ≥ stage 1 modified RIFLE criteria at any time within the first 7 days, OR new need for renal replacement therapy at any time from days 1 to 90. Excludes participants already on haemodialysis.</measure>
    <time_frame>Time period from randomisation (day 1) to day 90</time_frame>
    <description>&gt;=stage 1 modified RIFLE criteria (1.5-fold increase in the serum creatinine, or glomerular filtration rate (GFR) decrease by 25 percent). This endpoint does not apply to participants who were already on haemodialysis at randomisation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbiological relapse - positive blood culture for MRSA at least 72 hours after a preceding negative culture</measure>
    <time_frame>Time period from randomisation (day 1) to day 90</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbiological treatment failure. Positive sterile site culture for MRSA at least 14 days after randomisation</measure>
    <time_frame>Time period from randomisation (day 1) to day 90</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of intravenous antibiotic treatment</measure>
    <time_frame>Time period from randomisation (day 1) to day 90</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Direct health care costs</measure>
    <time_frame>Time period from randomisation (day 1) to day 90</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">440</enrollment>
  <condition>Methicillin-Resistant Staphylococcus Aureus</condition>
  <arm_group>
    <arm_group_label>Standard therapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Intravenous vancomycin dosed as per Australian Therapeutic Guidelines (loading dose of 25 mg/kg followed by maintenance dose of 15-20 mg/kg every 12 hours) with subsequent adjustment to maintain trough levels at 15-20 mg/dL OR Intravenous daptomycin 6-10 mg/kg per day, adjusted for renal function (details of renally adjusted dosing provided in full protocol).
The choice of daptomycin or vancomycin is clinician-determined and may be influenced by such factors as local practice, the vancomycin minimum inhibitory concentration (MIC) of the isolate and evidence emerging during the course of the study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard therapy + Beta-Lactam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In addition to standard treatment an intravenous Beta-Lactam (β-lactam) will be added for the first 7 calendar days following randomisation (randomisation is day 1 - hence patients will receive 6-7 days of β-lactam). This β-lactam will be intravenous flucloxacillin 2g every 6 hours in Australia and intravenous cloxacillin 2g every 6 hours in Singapore. For those with a history of minor allergy to any penicillin (rash or unclear history, but not anaphylaxis or angiooedema), it will be intravenous cefazolin 2g every 8 hours. For haemodialysis patients, it will usually be cefazolin 2g three times per week post dialysis, however clinicians are also free to choose intermittent (flu)cloxacillin, dosed as for glomerular filtration rate (GFR ) &lt;10, if they desire.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Beta-Lactam</intervention_name>
    <arm_group_label>Standard therapy + Beta-Lactam</arm_group_label>
    <other_name>flucloxacillin</other_name>
    <other_name>cloxacillin</other_name>
    <other_name>cephazolin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt;= 18 years.

          2. ≥1 set of blood cultures positive for MRSA

          3. Able to be randomized within 72 hours of blood cultures being collected.

          4. Likely to remain as inpatient for 7 days following randomization

        Exclusion Criteria:

          1. Previous type 1 hypersensitivity reaction to ß-lactams

          2. Polymicrobial bacteraemia (not counting contaminants)

          3. Previous participation in the trial

          4. Known pregnancy

          5. Current β-lactam antibiotic therapy which cannot be ceased or substituted

          6. Participant's primary clinician unwilling to enrol patient

          7. Moribund (expected to die in next 48 hours with or without treatment)

          8. Treatment limitations which preclude the use of antibiotics Note that we are NOT
             planning to exclude participants with renal failure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joshua Davis, MBBS, FRACP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Menzies School of Health Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steven Tong, MBBS, FRACP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Menzies School of Health Research</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joshua Davis, MBBS, FRACP</last_name>
    <phone>+61488191938</phone>
    <email>joshua.davis@menzies.edu.au</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Steven Tong, MBBS, FRACP</last_name>
    <phone>+618 89228928</phone>
    <email>steven.tong@menzies.edu.au</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Blacktown Hospital</name>
      <address>
        <city>Blacktown</city>
        <state>New South Wales</state>
        <zip>2148</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adrian Ong</last_name>
    </contact>
    <investigator>
      <last_name>Adrian Ong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred Hospital</name>
      <address>
        <city>Camperdown</city>
        <state>New South Wales</state>
        <zip>2050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian VanHal</last_name>
    </contact>
    <investigator>
      <last_name>Sebastian VanHal</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Concord Repatriation General Hospital</name>
      <address>
        <city>Concord</city>
        <state>New South Wales</state>
        <zip>2139</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Genevieve McKew</last_name>
    </contact>
    <investigator>
      <last_name>Genevieve McKew</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Vincent's Hospital</name>
      <address>
        <city>Darlinghurst</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Andresen</last_name>
    </contact>
    <investigator>
      <last_name>David Andresen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nepean Hospital</name>
      <address>
        <city>Kingswood</city>
        <state>New South Wales</state>
        <zip>2747</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Archana Sud</last_name>
    </contact>
    <investigator>
      <last_name>Archana Sud</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Liverpool Hospital</name>
      <address>
        <city>Liverpool</city>
        <state>New South Wales</state>
        <zip>2170</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hong Foo</last_name>
    </contact>
    <investigator>
      <last_name>Hong Foo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>John Hunter Hospital</name>
      <address>
        <city>New Lambton Heights</city>
        <state>New South Wales</state>
        <zip>2305</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joshua Davis</last_name>
      <email>joshua.davis@menzies.edu.au</email>
    </contact>
    <investigator>
      <last_name>Joshua Davis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Westmead Hospital</name>
      <address>
        <city>Westmead</city>
        <state>New South Wales</state>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew O'Sullivan</last_name>
    </contact>
    <investigator>
      <last_name>Matthew O'Sullivan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wollongong Hospital</name>
      <address>
        <city>Wollongong</city>
        <state>New South Wales</state>
        <zip>2500</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Niladri Ghosh</last_name>
    </contact>
    <investigator>
      <last_name>Niladri Ghosh</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Darwin Hospital</name>
      <address>
        <city>Darwin</city>
        <state>Northern Territory</state>
        <zip>0820</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Tong</last_name>
      <email>steven.tong@menzies.edu.au</email>
    </contact>
    <investigator>
      <last_name>Steven Tong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cairns Hospital</name>
      <address>
        <city>Cairns</city>
        <state>Queensland</state>
        <zip>4870</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Smith</last_name>
    </contact>
    <contact_backup>
      <last_name>Josh Hanson</last_name>
    </contact_backup>
    <investigator>
      <last_name>Simon Smith</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Josh Hanson</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Brisbane and Women's Hospital</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <zip>4029</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Paterson</last_name>
    </contact>
    <investigator>
      <last_name>David Paterson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Princess Alexandra Hospital</name>
      <address>
        <city>Woolloongabba</city>
        <state>Queensland</state>
        <zip>4102</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naomi Runnegar</last_name>
    </contact>
    <investigator>
      <last_name>Naomi Runnegar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Narin Bak</last_name>
    </contact>
    <investigator>
      <last_name>Narin Bak</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Flinder's Medical Centre</name>
      <address>
        <city>Bedford Park</city>
        <state>South Australia</state>
        <zip>5042</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas Anagnostou</last_name>
    </contact>
    <investigator>
      <last_name>Nicholas Anagnostou</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Queen Elizabeth Hospital</name>
      <address>
        <city>Woodville South</city>
        <state>South Australia</state>
        <zip>5011</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Morgyn Warner</last_name>
    </contact>
    <investigator>
      <last_name>Morgyn Warner</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Monash Medical Centre Clayton Campus</name>
      <address>
        <city>Clayton</city>
        <state>Victoria</state>
        <zip>3168</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ben Rogers</last_name>
    </contact>
    <investigator>
      <last_name>Ben Rogers</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dandenong Hospital</name>
      <address>
        <city>Dandenong</city>
        <state>Victoria</state>
        <zip>3175</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ben Rogers</last_name>
    </contact>
    <investigator>
      <last_name>Ben Rogers</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Western Health - Footscray</name>
      <address>
        <city>Footscray</city>
        <state>Victoria</state>
        <zip>3011</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Guy</last_name>
    </contact>
    <investigator>
      <last_name>Stephen Guy</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adrian Tramontana</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Austin Hospital</name>
      <address>
        <city>Heidelberg</city>
        <state>Victoria</state>
        <zip>3084</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Howden</last_name>
    </contact>
    <investigator>
      <last_name>Benjamin Howden</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Western Health - Sunshine Hospital</name>
      <address>
        <city>Sunshine</city>
        <state>Victoria</state>
        <zip>3021</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Guy</last_name>
    </contact>
    <investigator>
      <last_name>Stephen Guy</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adrian Tramontana</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Western Health - Williamstown Hospital</name>
      <address>
        <city>Williamstown</city>
        <state>Victoria</state>
        <zip>3016</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Guy</last_name>
    </contact>
    <investigator>
      <last_name>Stephen Guy</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adrian Tramontana</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fiona Stanley Hospital</name>
      <address>
        <city>Murdoch</city>
        <state>Western Australia</state>
        <zip>6150</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Owen Robinson</last_name>
    </contact>
    <investigator>
      <last_name>Owen Robinson</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul Ingram</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Perth Hospital</name>
      <address>
        <city>Perth</city>
        <state>Western Australia</state>
        <zip>6000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Owen Robinson</last_name>
    </contact>
    <investigator>
      <last_name>Owen Robinson</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul Ingram</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rambam Health Corporation</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mical Paul</last_name>
    </contact>
    <investigator>
      <last_name>Mical Paul</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beilinson Hospital</name>
      <address>
        <city>Petah Tikva</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dafna Yahav</last_name>
    </contact>
    <investigator>
      <last_name>Dafna Yahav</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Middlemore Hospital</name>
      <address>
        <city>Otahuhu</city>
        <state>Auckland</state>
        <zip>1640</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen McBride</last_name>
    </contact>
    <contact_backup>
      <last_name>Genevieve Walls</last_name>
    </contact_backup>
    <investigator>
      <last_name>Stephen McBride</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Genevieve Walls</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tan Tock Seng Hospital</name>
      <address>
        <city>Novena</city>
        <state>Tan Tock Seng</state>
        <zip>308433</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Lye</last_name>
    </contact>
    <investigator>
      <last_name>David Lye</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Kent Ridge</city>
        <zip>119074</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophia Archuleta</last_name>
    </contact>
    <investigator>
      <last_name>Sophia Archuleta</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Singapore General Hospital</name>
      <address>
        <city>Outram Park</city>
        <zip>168753</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tan Thuan Tong</last_name>
    </contact>
    <investigator>
      <last_name>Tan Thuan Tong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Israel</country>
    <country>New Zealand</country>
    <country>Singapore</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 11, 2015</study_first_submitted>
  <study_first_submitted_qc>February 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2015</study_first_posted>
  <last_update_submitted>March 28, 2018</last_update_submitted>
  <last_update_submitted_qc>March 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Methicillin-Resistant Staphylococcus aureus (MRSA)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Staphylococcal Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Cefazolin</mesh_term>
    <mesh_term>Methicillin</mesh_term>
    <mesh_term>Lactams</mesh_term>
    <mesh_term>beta-Lactams</mesh_term>
    <mesh_term>Cloxacillin</mesh_term>
    <mesh_term>Floxacillin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

